drugset / Trial / NCT01156688

A Prospective Randomized Comparison Trial on the Use of Mifepristone With Sublingual or Buccal Misoprostol for Medical Abortions of Less Than 9 Weeks Gestation

NCT01156688

Phase 4 Completed 90 enrolled The University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to compare the incidence of side effects of buccal and sublingual misoprostol when combined with mifepristone for medical abortions of less than 9 weeks gestation. The secondary outcome is to compare the complete abortion rate and induction-abortion interval between the two methods of administration of misoprostol.

Timeline

Start
2010-08
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.